Log in

Evidence that the anxiolytic-like effects of chlordiazepoxide on the elevated plus maze are confounded by increases in locomotor activity

  • Original Investigation
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

In exploratory animal models of anxiety, such as the elevated plus maze, the anxiogenic- and anxiolytic-like effects of drugs may be confounded by changes in locomotor activity. In the present experiments, the sensitivity of several measures of anxiety and locomotor activity in the elevated plus maze were assessed. Both chlordiazepoxide hydrochloride (CDP, 7.5 mg/kg) andd-amphetamine sulphate (AMP, 0.75, 1.5 mg/kg) increased the percent time on the open arms and doses of 7.5 mg/kg and 1.5 mg/kg CDP and AMP, respectively, increased the number of entries into the open arms. The increase in these measures might suggest that both compounds induced an anxiolytic-like effect. Although FG 7142 (30.0 mg/kg) did not decrease the number of entries to the open arms, it did decrease the time on the open arms, which might suggest that it had anxiogenic-like effects. Similarly, buspirone reduced both the number of entries into the open arms and the time spent on the open arms. However, all the compounds significantly affected locomotor activity. CDP (3.0 and 7.5 mg/kg) increased the total number of arm entries, the distance travelled on the open arms and the mean speed of the animals on the open, and in the closed arms. Moreover, the distance travelled by the animals in the closed arms was increased by 1.0 mg/kg CDP, a dose that had no measurable effects on the indices of anxiety. Similarly, although AMP failed to increase the total number of arm entries, it did increase the distance travelled in the closed arms (0.75 and 1.5 mg/kg), on the open arms (1.5 mg/kg) and the speed of the animals in the closed arms (1.5 mg/kg), a measure that is independent of the time spent in the closed arms. By contrast, both FG 7142 (30.0 mg/kg) and buspirone decreased the total number of arm entries (0.3–8.0 mg/kg), the speed of the animals in the closed arms and the distance travelled in the closed arms (1.0–4.0 mg/kg). These experiments suggest that: (i) the anxiogenic- and anxiolytic-like effects of drugs in the elevated plus-maze are confounded by changes in locomotor activity and that “total arm entries” is a relatively insensitive measure of drug-induced changes in locmotor activity; (ii) psychostimulant compounds, such as AMP, at doses that increase locomotor activity have an anxiolytic-like profile in the elevated plus maze and (iii) the measurement of speed of movement is a more sensitive index of changes in locmotor activity than the conventional measure of “total arm entries”.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Germany)

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Cole JC, Rodgers RJ (1994) Ethological evaluation of the effects of acute and chronic buspirone treatment in the murine elevated plus-maze test: comparison with haloperidol. Psychopharmacology 114:288–296

    Google Scholar 

  • Costall B, Kelly ME, Tomkins DM (1989) Use of the elevated plus maze to access anxiolytic potential in the rat. Br J Pharmacol 96:312P

    Google Scholar 

  • Dawson GR, Crawford SP, Stanhope JK, Iversen SD, Tricklebank MD (1994) One-trial tolerance to the effects of chlordiazepoxide on the elevated plus maze may be due to locomotor habituation, not repeated drug exposure. Psychopharmacology 113:570–572

    Google Scholar 

  • File SE (1991) The biological basis of anxiety. In: Meltzer HY, Nerozzi D, (eds) Current practices and future developments in the pharmacotherapy of mental disorders. Elsevier, Amesterdam, pp 159–165

    Google Scholar 

  • Handley SL, McBlane JW (1993) An assessment of the elevated X-maze for studying anxiety and anxiety-modulating drugs. J. Pharmacol Toxicol Methods 29:129–138

    Google Scholar 

  • Kaiser FC, Palmer GC, Wallace AV, Carr RD, Fraser RL, Hallam C (1992) Antianxiety properties of the angiotensin II antagonist, DUP 753, in the rat using the elevated plus-maze. Neuroreport 3:922–924

    Google Scholar 

  • Killcross AS, Dickinson A, Robbins TW (1994) Amphetamine-induced disruptions of latent inhibition are reinforcer mediated: implications for animal models of schizophrenic attentional dysfunction. Psychopharmacology 115:185–195

    Google Scholar 

  • Lister RG (1987) The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology 92:180–185

    Google Scholar 

  • Lister RG (1991) Ethologically based animal models of anxiety disorders. In: File SE (ed) Psychopharmacology of anxiolytics and antidepressants. Pergamon New York, pp 155–185

    Google Scholar 

  • Luscombe GP, Mazurkiewicz SE, Heal DJ (1992) The 5HT1A ligands BP 554 mimics the anxiolytic activity of buspirone, geprione and ipsapirone in the elevated plus maze in rats. Br J Pharmacol 105:221P

    Google Scholar 

  • Moser PC (1989) An evaluation of the elevated plus-maze using the novel anxiolytic buspirone. Psychopharmacology 99:48–53

    Google Scholar 

  • Moser PC, Hibert M, Mirk AK, Tricklebank MD, Fosard JR (1988) Effects of MDL 73005EF in animal models predictive of anxiolytic activity. Br J Pharmacol 93:3P

  • Pellow S, File SE (1986) Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus maze: a novel test of anxiety in the rat. Pharmacol Biochem and Behav 24:525–529

    Google Scholar 

  • Pellow S, Chopin P, File SE, Briley M (1985) Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 14:149–167

    Google Scholar 

  • Pellow S, Johnston, AL, File SE (1987) Selective agonists and antagonists for 5-hydroxytryptamine receptor subtypes, and interactions with yohimbine and FG 7142 using the elevated plus-maze test in the rat. J Pharm Pharmacol. 39:917–928

    Google Scholar 

  • Robbins TW, Iversen SD (1973) A dissociation of the effects ofd-amphetamine on locomotor activity and exploration in rats. Psychopharmacologia 28:155–164

    Google Scholar 

  • Ryan CN, Evenden JL, Petterson M (1993) Effects of buspirone and ipsapirone on schedule induced polydipsia: comparison with 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) and raclopride. Psychopharmacology 112:34–44

    Google Scholar 

  • Söderpalm B, Hjörth S, Engel JA (1989) Effects of 5-HT1Areceptor agonists andl-5HTP in Montgomery's conflict test. Pharmacol Biochem Behav 32:259–265

    Google Scholar 

  • Thiébot MH, Soubrié P, Sanger D (1988) Anxiogenic properties of beta-CCE and FG 7142: a review of promises and pitfalls. Psychopharmacology 94:452–463

    Google Scholar 

  • Triet D (1985) Animal models for the study of anti-anxiety agents: a review. Neurosci Biobehav Rev 9:203–222

    Google Scholar 

  • Triet D (1991) Anxiolytic effects of benzodiazepines and 5-HT1A agonists: animal models. In: Rodgers RJ, Cooper SJ (eds) 5-HT1A agonists 5-HT3 antagonists and benzodiazepines. Wiley, UK

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

All the experiments reported in this manuscript were conducted within British Government Home Office approved techniques, procedures and project licences.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dawson, G.R., Crawford, S.P., Collinson, N. et al. Evidence that the anxiolytic-like effects of chlordiazepoxide on the elevated plus maze are confounded by increases in locomotor activity. Psychopharmacology 118, 316–323 (1995). https://doi.org/10.1007/BF02245961

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02245961

Key words

Navigation